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Mesoderm is induced at the primitive streak (PS) and
patterns subsequently into mesodermal subtypes
and organ precursors. It is unclear whether meso-
derm induction generates a multipotent PS progeni-
tor or several distinct ones with restricted subtype
potentials. We induced mesoderm in human pluripo-
tent stemcellswithACTIVINandBMPorwithGSK3-b
inhibition. Both approaches induced BRACHYURY+
mesoderm of distinct PS-like identities, which had
differing patterning potential. ACTIVIN and BMP-
induced mesoderm patterned into cardiac but not
somitic subtypes. Conversely, PS precursors
induced by GSK3-b inhibition did not generate
lateral plate and cardiac mesoderm and favored
instead somitic differentiation. The mechanism of
these cell fate decisions involved mutual repression
of NANOGandCDX2. AlthoughNANOGwas required
for cardiac specification but blocked somitic sub-
types, CDX2 was required for somitic mesoderm
but blocked cardiac differentiation. In sum, rather
than forming a common PS progenitor, separate in-
duction mechanisms distinguish human mesoderm
subtypes.
INTRODUCTION
Organ development in vertebrates begins with induction of
the primary embryonic tissue layers ectoderm, mesoderm, and
endoderm, and their subsequent patterning into specific tissue
subtypes. The induction of mesoderm from pluripotent cells
marks the onset of this process, evidenced by primitive streak
(PS) formation (Arnold and Robertson, 2009; Stern et al., 2006;
Tam and Loebel, 2007). The specification of mesoderm in the
vertebrate embryo is initiated and driven by dynamic bone
morphogenetic protein (BMP), NODAL/ACTIVIN, fibroblast
growth factor (FGF), and WNT signaling gradients along the
anterior-posterior axis of the embryo and the PS (Figure 1A).
The same signaling activities are also essential for subsequent
spatial and temporal allocation (or patterning) of mesodermal
subtypes after PS induction. Fate-mapping experiments in310 Cell Stem Cell 15, 310–325, September 4, 2014 ª2014 Elsevier Ivertebrates show that mesoderm patterning into subtypes
strictly correlates with the place and time of mesoderm induction
in the PS (Lawson et al., 1991; Tam et al., 1997). For instance,
anterior-specific subtypes include anterior lateral plate and
cardiac mesoderm, whereas extraembryonic and somitic meso-
derm is exclusively posterior. However, it remains unclear how
mesoderm induction and its patterning into organ precursors
depend on diverse and changing signals during initial
differentiation.
Mesoderm and its subtypes can be generated in vitro from hu-
man pluripotent stem cells (hPSCs), which provide a model of
early human development and a major source of therapeutically
relevant cell types (Murry and Keller, 2008; Nishikawa et al.,
2007). Mesoderm can be induced from hPSCs by a remarkably
wide range of conditions, including different signals that are pre-
sent during PS formation (Kattman et al., 2011; Mae et al., 2013).
Regardless of induction method, a common feature is expres-
sion of the early pan-mesodermal marker gene BRACHYURY
(BRA) (Martin and Kimelman, 2010). However, there is no
comprehensive human mesoderm induction and patterning
model to test how different BRA and mesoderm induction sig-
nals direct efficient generation of distinct mesodermal subtypes
and tissues.
At present, the dominant view is that different signaling envi-
ronments during PS induction lead to a BRA+ multipotent and
unrestricted mesoderm progenitor that can be further specified
into all mesodermal subtypes (Figure 1B). In an alternative
model, different PS mesoderm induction signals could generate
restricted BRA+mesoderm progenitors with differing potential to
form distinct mesodermal subtypes. These two hypotheses lead
to different and testable expectations regarding (1) different
mechanisms of BRA induction, (2) distinct molecular identities
of induced BRA+ mesoderm, and (3) the dependency of meso-
derm subtype specification on the initial PS induction mecha-
nism. Finally, we hypothesized that if direction into distinct
mesodermal subtypes depended on PS mesoderm induction,
this could involve mutually exclusive exit mechanisms from
pluripotency.
We tested these hypotheses by inducing PS mesoderm in
hPSCs using FGF signaling in combination with ACTIVIN and
BMP or with glycogen synthase kinase 3 b (GSK3-b) inhibition
followed by subsequent specification into different meso-
dermal subtypes. First, we determined how these signaling
pathways independently activated BRA expression. We then
demonstrated that these different mechanisms of BRA and PSnc.
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Finally, we showed that ACTIVIN/BMP and GSK3-b mediated
these effects via NANOG and CDX2, respectively. Accordingly,
our findings provide valuable insights into lineage specification
mechanisms of therapeutically relevant tissues and organs.
RESULTS
Human PSCs can be differentiated into anterior PS-like (Anteri-
orPS) cells by combining phosphatidylinositol 3-kinase inhi-
bition (using LY294002 [Ly]) with FGF2 (F), ACTIVIN A (A), and
BMP4 (B), whereas Ly plus F and B induce posterior PS-like
(PosteriorPS) cells (Bernardo et al., 2011; McLean et al.,
2007). Subsequent differentiation leads to functional tissue
derivatives of these PS regions (Figure S1A available online)
(Cheung et al., 2012; Cho et al., 2012; Loh et al., 2014; Touboul
et al., 2010). In addition to these signals, canonical WNT-driven,
GSK3-b-mediated b-CATENIN signaling is a key pathway in
mesoderm induction both in vivo and in vitro (Arnold and Rob-
ertson, 2009; Murry and Keller, 2008). WNT ligands lead,
among other effects, to inhibition of GSK3-b activity causing
stabilization of nuclear b-CATENIN, which acts as a potent
transcriptional coactivator (Nusse and Varmus, 2012). To mimic
these signals, we combined WNT agonists (recombinant
WNT3A) or the GSK3-b inhibitor CHIR99021 (Ch) with Anteri-
orPS and PosteriorPS treatments in order to model vertebrate
PS induction. Despite general advantages of small molecules
like Ch in driving pluripotent stem cell (PSC) differentiation,
we bore in mind that GSK3-b is not an exclusive mediator of
WNT or b-CATENIN signaling and that it mimics only one of
several WNT pathway branches. We then used F, A, B, and
Ch separately and in combination to distinguish between direct
patterning into subtypes by PS mesoderm induction versus
patterning after PS induction of a multipotent mesoderm pre-
cursor (Figure 1B).
ACTIVIN/BMP Signaling and GSK3-b Inhibition Can Both
Induce Mesoderm
Unlike NODAL and BMP, which form anterior-posterior signaling
gradients in the early vertebrate PS, FGF and WNT signaling is
active throughout the PS at all stages (Aulehla and Pourquie´,
2010). Accordingly, we inhibited GSK3-b using Ch in combina-
tion with either F alone or AnteriorPS or PosteriorPS conditions.
Cells induced to differentiate with Ch showed a distinctive,
cobblestoned morphology and strong upregulation of pan-PS
markers BRA and TBX6 compared to PosteriorPS and Anteri-
orPS treatments (Figures S1C, 1C, 1E, and S1D). We confirmed
this in live hPSCs carrying a fluorescent reporter of endogenous
BRA transcription involving a histone 2B (H2B)-Venus fusion
knockin (Figure 1D). We observed higher levels, more homoge-
neous population intensity peaks, and widespread activation of
BRA expression with Ch (Figures 1C and 1D). An immunoflow
analysis of BRA protein suggests more transient dynamics
of BRA up- and downregulation with AnteriorPS treatment as
compared to F plus Ch (Figure S1D). In conclusion, whereas
GSK3-b inhibition strongly induced BRA and TBX6, ACTIVIN
and BMP signaling induced them only moderately. However, it
remained unclear whether these different PS induction mecha-
nisms were similar or distinct.Cell SBecause GSK3-b inhibition can markedly boost BRA ex-
pression, we asked whether it could do this independently of
exogenous FGF, ACTIVIN, or BMP signaling. Exogenous F and
Ch were sufficient to induce the BRA-VENUS-H2B reporter,
BRA transcription, and protein expression (Figures 1C, 1F,
and S1D). Moreover, when we blocked ACTIVIN (SB431542
[Sb], SIS3), BMP (Dorsomorphin), and FGF/ERK pathways
(SU5402, PD0325901), we still observed significant induction
of BRA transcript and protein expression by GSK3-b inhibition
alone (Figures 1G, S1E, and S1F). By contrast, PosteriorPS
and AnteriorPS induction of BRA expression depended entirely
on ACTIVIN/BMP combined with FGF signaling (Figures 1C
and S1E).
We then asked the reciprocal question whether WNT and
GSK3-b signaling is essential for ACTIVIN/BMP-dependent
BRA induction. WNT Luciferase reporter activity and upregula-
tion of the WNT target AXIN2 in PosteriorPS cells were initially
very low (after 18 hr) and increased only later (after 36 hr)
compared to conditions containing WNT agonists (WNT3A,
R-Spondin, or Ch). This is in agreement with the identification
of WNT3/WNT3A as targets of BRA (Figures 1H and 1I) (Evans
et al., 2012; Martin and Kimelman, 2008). Furthermore, inhibition
of WNT signaling in PosteriorPS cells (using DKK1 or IWR1) did
not diminish induction of BRA or the mesoderm marker
MESP1, which is consistent with the modest nuclear localization
of b-CATENIN in PosteriorPS cells (Figures S1H, 1J, and S1G).
These results indicated that PosteriorPS induced BRA expres-
sion in the presence of low endogenous canonical WNT
signaling. We concluded that ACTIVIN/BMP signaling and
GSK3-b inhibition could act in parallel to induce expression of
pan-mesodermal marker genes.
ACTIVIN/BMP and GSK3-b Control BRA Expression via
Distinct Transcriptional Regulatory Elements
To clarify how diverse mesoderm induction mechanisms
intersect at the BRA locus, we performed chromatin immuno-
precipitation (ChIP) followed by quantitative PCR (qPCR)
for chromatin binding components of the ACTIVIN (SMAD2/
SMAD3), BMP (SMAD1/SMAD5), and canonical WNT
(b-CATENIN) pathways in pluripotency, AnteriorPS, and Ante-
riorPS plus Ch conditions. We observed SMAD2/SMAD3 and
SMAD1/SMAD5 binding to two putative regulatory regions
(proximal and distal; Figures 2A, S2A, and 2C) upstream of
BRA in both differentiation conditions. SMAD2/SMAD3 bound
both proximally and distally, but SMAD1/SMAD5 bound pre-
dominantly distally in a region with known DNase hypersensi-
tivity and a putative enhancer (Figure S2A; Loh et al., 2014). By
contrast, b-CATENIN bound mainly in the AnteriorPS plus Ch
condition to the proximal promoter region. SMAD2/SMAD3
bound mostly to the proximal promoter region in pluripotent
conditions. Luciferase assay analysis further confirmed that
only a long 6 kb fragment containing the distal SMAD1/
SMAD5 site could drive BRA expression in PosteriorPS condi-
tion (Figure 2B). By contrast, a short 1 kb fragment containing
the proximal promoter was sufficient to strongly stimulate
BRA expression by the PosteriorPS plus Ch condition. We
concluded that induction of BRA is mediated by distinct tran-
scriptional regulatory elements. Taken together, these results
demonstrate how a limited set of signals can induce BRAtem Cell 15, 310–325, September 4, 2014 ª2014 Elsevier Inc. 311
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Figure 1. ACTIVIN/BMP Signaling and GSK3-b Inhibition Can Both Induce Mesoderm
(A) Simplified scheme of mesoderm induction and patterning defined by signaling gradients (BMP high in posterior; NODAL/ACTIVIN high in anterior) and
activities (FGF and WNT high in streak) in distinct regions of the PS at different stages.
(B) Two hypothetical models of mesoderm induction and patterning.
(legend continued on next page)
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have sufficient complexity to generate potentially different
mesoderm subtypes.
ACTIVIN/BMP Signaling or GSK3-b Inhibition Induces
Distinct AnteriorPS, PosteriorPS, and LatePS
Mesodermal Identities
In contrast to BRA and TBX6, which are expressed throughout
PS development, other early mesodermal markers show more
localized expression in either the anterior or the posterior of
the early PS or in the late PS at the onset of somitogenesis
(Aulehla and Pourquie´, 2010; Tam and Loebel, 2007). We there-
fore asked whether other key mesodermal markers were coex-
pressedwith BRA in either ACTIVIN/BMP-dependent treatments
or in conditions with GSK3-b inhibition, using RT-qPCR, immu-
nocytochemistry, and immunoflow analysis. As previously
shown, PosteriorPS cells induced early PS, extraembryonic,
and lateral plate mesoderm transcripts (CDX2, HAND1, KDR,
andMESP1), whereas AnteriorPS cells induced mid and anterior
PSmarkers (EOMES andGSC; Figures 3A, 3C, and 3E; Bernardo
et al., 2011). By contrast, AnteriorPS plus Ch and PosteriorPS
plus Ch treatments both induced exclusively markers of late
PS and presomitic mesoderm (MSGN1, TBX6, CDX1, CDX2,
and CDX4; Figures 3A, 3B, S3B, and S3C). Because F plus Ch
alone also activated all of these late PS mesoderm markers,
we regarded this condition as inducing late PS-like (LatePS) dif-
ferentiation (Figures 3A, 3C, and 3D). Furthermore, we found that
CDX2 expression levels, similar to BRA, depended on Ch
dosage (3 versus 8 mM) and that both markers strongly colocal-
ized (Figure S3A). These results echoed vertebrate embryo
gastrulation, where a gradient of strong, posterior WNT and
FGF signaling induces high levels of BRA, TBX6, and CDX pro-
teins in the late PS mesoderm (Aulehla and Pourquie´, 2010;
Lohnes, 2003). Importantly, the identification of distinct BRA+
PS mesoderm progenitors (AnteriorPS versus PosteriorPS
versus LatePS; Figure 3D) allowed us to test whether they are
multipotent or restricted in their subsequent subtype specifica-
tion potential. The strengths of this in vitro model thus enabled
a rigorous analysis of the mechanism whereby cells exit pluripo-
tency and become specified into mesodermal subtypes.
AnteriorPS Induction, but Not PosteriorPS Induction,
Patterns hPSCs into Cardiac Mesoderm
We previously used PosteriorPS induction to subsequently
pattern hPSCs into lateral plate mesoderm (with F plus B) and(C) RT-qPCR analysis of transcript levels for the general PS markers BRA and TBX
(FGF) plus Ly AnteriorPS (AntPS; FGF plus ACTIVIN plus BMP plus Ly), Posterior
Further details are in Experimental Procedures.
(D) Confocal images of live H9 hESCs with Venus-H2B reporter targeted to the e
(E) Confocal images of H9 hESCs (Pluri) or after 36 hr in PosteriorPS conditions.
(F) Flow cytometry of H9 hESCs showing BRA levels and expression dynamics i
(G) GSK3-b inhibition independently induces BRA and TBX6. RT-qPCR analysis o
B, Dorsomorphin (Do), SU5402 (Su), or SB431542 (Sb) is shown.
(H) Luciferase WNT activity reporter assay in stably transfected DN-b-CATENIN-E
with WNT3A (W), R-SPONDIN-1 (R), or 4-hydroxy-tamoxifen (Tam).
(I) RT-qPCR expression analysis of the canonical WNT signaling target gene AXI
(J) PosteriorPS conditions induce BRA independently of canonical WNT signalin
stabilizer IWR1 (Iwr).
*p < 0.05, **p < 0.005, versus Pluri or pairwise as indicated by bar. Scale bars, 1
Cell Sto differentiate further into functional smooth muscle cells
(SMCs) (Bernardo et al., 2011; Cheung et al., 2012). We now
used this approach to ask whether PosteriorPS induction could
give rise to other lateral plate derivatives such as cardiac meso-
derm and beating cardiomyocytes.
In vivo studies implicate retinoic acid (RA) and inhibition
of canonical WNT signaling in mesoderm patterning into the
cardiac lineage (Marvin et al., 2001; Niederreither et al., 2001).
Consistent with this, we combined RA and IWR1 (AXIN stabilizer
inhibiting canonical WNT signaling) during lateral plate treatment
and boosted expression of cardiac markers NKX2-5, TBX5,
MYH6, and MYL7 after 5 days of differentiation (Figures 4A and
S4A). However, further differentiation did not result in beating
cardiomyocytes, and cardiac structural marker expression
decreased (data not shown). If mesoderm induction affects later
mesoderm patterning, PosteriorPS induction might not support
formation of somemesoderm subtypes, including cardiac. Alter-
natively, the multipotent mesoderm precursor hypothesis pre-
dicts that all PS treatments should generate cardiac progenitors
and beating cardiomyocytes.
We examined these possibilities using different PS treatments
followed by a 6-day chemically defined, 2D cardiac differentia-
tion protocol involving F plus B together with RA and IWR1.
Strikingly, whereas AnteriorPS treatment induced robust forma-
tion of beating clusters, PosteriorPS or PosteriorPS plus Sb
induction followed by identical treatment did not result in
cardiac differentiation (Figure 4B). Functional cardiomyocyte dif-
ferentiation was achieved at a wide range of A concentrations
(20–100 ng/ml) but most effectively at intermediate levels
(50 ng/ml; Figures 4C and S5A). This method was successfully
employed with different human embryonic stem cell (hESC)
lines and with induced hPSCs (HES3, H7, H9, and BOB; Figures
4C and S4B). When generated at lower initial seeding densities,
we could quantify functional beating clusters, whereas higher
seeding densities resulted in cluster networks or beating
cardiomyocyte sheets (Movie S1). AnteriorPS-induced cells
upregulated cardiac structural markers MYL7, TROPO-T, and
a-ACTININ as well as endogenous NKX2-5, as shown using
the GFP reporter gene knockin HES3 hPSC line (Figure 4C).
By contrast, PosteriorPS or PosteriorPS plus Sb treatments
did not activate or maintain high expression of key cardiac
transcription factors NKX2-5, ISL1, HAND1, and GATA6 (Figures
S4C and S4D). Our results suggest that the prerequisite for
efficient cardiac specification occurs in the first 36 hr of meso-
derm induction. These results do not support the hypothesis6 in H9 hESCs grown in pluripotency conditions (Pluri; FGF plus ACTIVIN) or F
PS (PostPS; FGF plus BMP plus Ly), or with FGF plus the GSK3-b inhibitor Ch.
ndogenous BRA locus.
n AnteriorPS and FGF plus Ch conditions.
f transcript levels of BRA and TBX6with indicated combinations of Ch and F, A,
R-inducible H9 hESCs after 18 and 36 hr of differentiation induced by FGF (F)
N2 in indicated conditions.
g, as shown by treatment with the WNT receptor inhibitor DKK-1 or the AXIN
00 mM.
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Figure 2. ACTIVIN/BMP Signaling and GSK3-b Inhibition Control BRA Expression via Distinct Transcriptional Regulatory Elements
(A) ChIP-qPCR analysis of SMADs and b-CATENIN binding performed using primers as shown in Figure S2A.
(B) Luciferase reporter analysis of transiently transfected H9 hESCs with indicated fragments (A).
(C) Model of SMAD1/5, SMAD2/3, and b-CATENIN binding.
*p < 0.05, **p < 0.005, versus control or pairwise as indicated by bar.
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equivalent capabilities for cardiomyocyte development follow-
ing PosteriorPS or AnteriorPS induction. They favor instead the
alternative hypothesis of early mesodermal subtype patterning
via PS precursors of restricted differentiation potential.
GSK3-b Inhibition during AnteriorPS Induction Blocks
Cardiac Specification
Although A and B were both required during AnteriorPS
induction for efficient cardiac differentiation, the roles of WNT
signaling and GSK3-b inhibition were unclear at this stage.
Modest GSK3-b inhibition by Ch (3 mM) or inhibition of upstream
WNT signaling (both canonical and noncanonical) by IWP2 dur-
ing AnteriorPS induction prevented specification into beating,
a-ACTININ+ cardiomyocyte clusters (Figure 4D). Consistent314 Cell Stem Cell 15, 310–325, September 4, 2014 ª2014 Elsevier Iwith this, Ch and IWP2 treatment during induction inhibited
the upregulation of the lateral plate mesoderm markers
MESP1, NKX2-5, ISL1, GATA6, and HAND1 after lateral plate
and cardiac differentiation (Figures 4F, S4F, and S4E). This inhib-
itory effect of Ch during PS induction was not due to nuclear
b-CATENIN because Tam-induced translocation of stably trans-
fected DN-b-CATENIN-ER did not block NKX2-5 upregulation
(Figures S4F, 1H, and 6D). Moreover, Ch did not inhibit cardiac
differentiation when it was added after the initial induction step
(Figure S4G). In contrast to Ch or IWP2, inhibition of canonical
WNT signaling by AXIN stabilizers IWR1 or XAV939 during
AnteriorPS induction did not affect cardiac differentiation
(Figure 4D). We therefore hypothesized and confirmed that
additional, noncanonical WNT-JNK signaling is required during
cardiogenic AnteriorPS induction (Figures 4D and 4E). Takennc.
AB C
D E
Figure 3. ACTIVIN/BMP Signaling or GSK3-b Inhibition Induces Distinct PosteriorPS, AnteriorPS, and LatePS Mesodermal Identities
(A) RT-qPCR analysis of indicated early mesodermal transcripts in H9 hESCs grown in mesoderm-inducing conditions.
(B) F plus inhibition of GSK3-b (LatePS) induces the late PS marker CDX1, which colocalizes with BRA and is not upregulated by PosteriorPS treatment.
Representative confocal images of H9 hESCs are shown.
(legend continued on next page)
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early PS induction is critical for later patterning of mesoderm into
lateral plate and cardiac subtypes.
Cardiac mesoderm and definitive endoderm (DE) share the
requirement for the anterior PS marker EOMES, which has
been shown to activate the precardiac determinant MESP1
(Costello et al., 2011). We found that inhibition of GSK3-b or in-
hibition of ACTIVIN signaling blockedMESP1 and EOMES upre-
gulation during AnteriorPS induction (Figures 3A, 4F, and 4G). In
agreement with this, hPSCs in DE plus Ch condition did not
upregulate DEmarkers EOMES, SOX17, and FOXA2, suggesting
that strong GSK3-b inhibition also prevented DE differentiation
(Figures 4G, S4H, and S4I). These effects were independent of
nuclear b-CATENIN and depended instead on Ch dosage and
exogenous F and B (Figures S4K, 4G, 4D, and S4J). In summary,
derivatives of the early mid and anterior PS: DE, lateral plate, and
cardiac mesoderm are blocked by strong inhibition of GSK3-b
or inhibition of ACTIVIN signaling during PS induction. These
signals lead instead to the upregulation of CDX2, a marker and
determinant of posterior extraembryonic mesoderm and the
late PS (Figure S4L; Lohnes, 2003).
LatePS and PosteriorPS Cells Are Committed and
Cannot Undergo Patterning into Cardiac Lineage
DE is known to have an inductive role in cardiac specification
in vivo and in vitro (Mummery et al., 2007; Schultheiss et al.,
1995). A possible explanation for the negative effect of GSK3-b
inhibition on cardiac differentiation is that cardiogenic inductive
signals from FOXA2+ AnteriorPS or DE cells are absent (Figures
5A and S5A). We therefore tested whether GFP-labeled LatePS
cells could differentiate efficiently into cardiac lineage when
they were mixed with nonlabeled AnteriorPS cells during cardiac
differentiation. Interestingly, GFP-labeled LatePS-induced cells
could not generate beating cardiac clusters even in the presence
of AnteriorPS-derived nonlabeled cells, suggesting that they are
already committed to other fates (Figure 5B). Similarly, GFP-
labeled PosteriorPS cells mixed with unlabeled AnteriorPS cells
did not generate beating clusters (data not shown). This result
does not contradict the established role of DE during later car-
diac specification but argues against a dominant instructive
role during AnteriorPS induction. Accordingly, we hypothesized
that PosteriorPS and LatePS conditions cannot generate cardiac
mesoderm because they induce early lineage determinants that
drive commitment to other mesodermal subtypes.
LatePS Induction Promotes Patterning into (Pre)Somitic
Mesoderm in Contrast to PosteriorPS and AnteriorPS
Induction
According to our models in Figures 3D and S4L, LatePS treat-
ment was sufficient to induce presomitic mesoderm markers
that are expressed in the posterior region of the embryo after
formation of DE, lateral plate, and cardiac mesoderm. The hy-
pothesis that mesoderm subtype patterning depends on PS in-(C) Time course immunoflow cytometry quantification of CDX2+ cells in AnteriorP
(D) Hypothesized human in vitro PS induction model.
(E) Representative confocal images of PS treatments, showing mutually exclusiv
**p < 0.005, versus Pluri. Scale bars, 100 mM.
316 Cell Stem Cell 15, 310–325, September 4, 2014 ª2014 Elsevier Iduction predicts that further patterning treatments on LatePS
cells would generate (pre)somitic (presomitic and somitic) meso-
dermprecursors ofmuscle andcartilage insteadof lateral plate or
cardiac mesoderm. We treated LatePS cells with RA and a lower
dose of F thereby mimicking conditions during (pre)somitic
mesoderm differentiation in the vertebrate embryo (Aulehla and
Pourquie´, 2010). We observed the upregulation of (pre)somitic
markers (TCF15, MESP2, MEOX1, MYF5, PAX1, ZO-1, SOX9,
and PAX3); conversely, the PS marker TBX6 was efficiently
downregulated (Figures 5C, 5D, 5H, S5B, andS5C). Interestingly,
upregulation of PAX3 (together with PAX7, the key determinants
of the skeletalmuscle lineage) andSOX9 (early sclerotome/chon-
drogenic determinant) was completely blocked by B in LatePS
and by PosteriorPS or AnteriorPS induction (Figures 5D and
5E). Importantly, whenwe treated cells after (pre)somitic differen-
tiation with F plus B as we did during cardiac differentiation, we
observed specific upregulation of chondrogenic (cartilage)
markers COL2A1 and ACAN instead of cardiac markers (Figure
S5E). To confirm that LatePS-derived (pre)somitic cells differen-
tiated into chondrogenic, extracellularmatrix-producingcells,we
used Alcian blue and found widespread proteoglycan staining
(Figure 5F). Moreover, PosteriorPS or AnteriorPS induction with
identical subsequent treatments resulted in inefficient chondro-
genic differentiation, confirming that GSK3-b inhibition used in
LatePScondition is crucial for subsequent somite-likemesoderm
specification. In conclusion, whereas PosteriorPS and Anteri-
orPS induction promotes subsequent patterning into lateral plate
and cardiac mesoderm, LatePS conditions instead promote
patterning into (pre)somitic fates (model in Figure 5G).SMCs Can Be Generated after AnteriorPS, PosteriorPS,
and LatePS Mesoderm Induction
Weasked next whether patterning of all mesoderm cell types de-
pends on early PS induction. SMCs are a particularly interesting
case because these are generated at all stages and from all seg-
ments of thePSandcouldbe therefore less sensitive toPSmeso-
derm induction conditions (Majesky, 2007). Accordingly, we
inducedPSmesodermwithAnteriorPS, PosteriorPS, andLatePS
conditions and then applied an identical lateral plate patterning
treatment (F plus B) followed by functional SMC differentiation
(platelet-derived growth factor BB [PDGF-BB] plus transforming
growth factor b [TGF-b]; Figures 5I and S5D). These SMCs
showed clear morphological differences suggesting that they
were separate populations with distinct developmental origins
as seen before (Figure S5F; Cheung et al., 2012). After 9 days
of SMC differentiation, all three induction treatments resulted in
the expression of key SMC markers (CNN1, ACTA2, MYH11,
and TAGLN; Figures 5I and S5D) in the absence of other meso-
dermal markers (NKX2.5, PAX3, and BRA; data not shown). Up-
regulation of these markers was blocked by (pre)somitic
patterning treatment (F plus RA; Figure 5I). Importantly, upon
treatment with Carbachol (which induces SMC contractions),
SMCsderived fromall PS treatments showed contractile activity,S and LatePS conditions.
e CDX2 and EOMES expression.
nc.
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Figure 4. AnteriorPS Induction Is Required for Cardiac Specification
(A) RA treatment and inhibition of canonical WNT signaling by IWR1 (Iwr) promote the expression of cardiac transcription factors TBX5 and NKX2-5 as well as
cardiomyocyte structural proteins MYL7 and MYH6 during lateral plate mesoderm (LPM; F+B, 4 days) differentiation in H9 hESCs (see protocol in Figure S4L).
(legend continued on next page)
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PosteriorPS-derived extraembryonic cells did not (Figures 5J,
S5F, and S5G). Taken together, these findings support the hy-
pothesis thatmesoderm subtype specification beginswith PS in-
duction, and they argue against amultipotentmesodermprogen-
itor. This effect is particularly clear with mesodermal subtypes
that emerge at a defined time and place during PS formation.
We therefore explored themolecular basis of these cell fate deci-
sions and examined determinants capable of directing meso-
dermal patterning at the earliest stages of PS exit from pluripo-
tency and ensuing differentiation.
PosteriorPS, AnteriorPS, and LatePS PatternMesoderm
via NANOG and CDX2
Two linked processes occur during AnteriorPS-, PosteriorPS-,
and LatePS-induced differentiation: dynamic downregulation
of so-called pluripotency factors (e.g., OCT4, SOX2, and
NANOG); and the upregulation of early lineage determinants
(e.g., BRA, EOMES, and CDX2). At first, we focused on NANOG
because its expression differed most extensively between the
distinct mesoderm induction conditions we employed here.
Although NANOG expression was rapidly downregulated within
24 hr of GSK3-b inhibition and by reduced or blocked ACTIVIN
signaling, it persisted in AnteriorPS cells (Figures 6A and 6B).
NANOG protein colocalized with EOMES and was coexpressed
with MESP1 during the first 24–48 hr in AnteriorPS condition
(Figures 6C and S6A). Notably, in AnteriorPS plus Ch induction,
cells with high EOMES were distinct from those with high CDX2
protein levels (only 1.4% signal overlap; Figure S4I). Conversely,
CDX2 expression was strongly upregulated in conditions where
ACTIVIN signaling and NANOG expression were absent and
either inhibition of GSK3-b or B was present (Figure 6A). The
inhibitory effect of Ch on NANOG and EOMES expression in
AnteriorPS condition could be reversed by IWR1 treatment.
This coincided with partial b-CATENIN relocation to the cyto-
plasm and downregulation of CDX2 (Figures S6B and S6C). In
contrast to induction of BRA, transcriptional activation by induc-
ible nuclear b-CATENIN was not sufficient to downregulate
NANOGor to upregulate CDX2, suggesting alternative regulation
(Figure 6D). However, activation of CDX2 expression was still
absolutely dependent on Ch (Figure S6D). These observations
strongly implicate additional mediators of GSK3-b signaling
as being involved in mesoderm induction and patterning. We
concluded that PosteriorPS, AnteriorPS, and LatePS induction
differed not only by differentiation marker expression but also
in the exit mechanism from pluripotency.(B) Indicated PS induction treatments followed by cardiac differentiation as in (A)
inhibited by Sb. Beating clusters were counted in triplicate after 8 days of differe
(C) Beating cardiomyocytes express major cardiac structural proteins in targete
indicated.
(D) Inhibition of upstreamWNT signaling by IWP2 (Iwp), of GSK3-b by Ch and of JN
in H9 hESCs. AXIN stabilization by IWR1 (Iwr) or XAV939 (Xav), PKC inhibition by
effect. a-ACTININ+ beating clusters were counted as in (B) (right side of each pa
(E) Phosphorylation of JNK1/JNK2 is reduced by noncardiogenic treatments dur
(F) GSK3-b inhibition blocks expression of lateral plate mesodermmarkers in H9 h
B (D3/D4).
(G) Representative confocal images of a DN-b-CATENIN-ER-inducible H9 hESC c
(Tam).
*p < 0.05; **p > 0.005 versus LPM or D0. Scale bars, 100 mM.
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Mesodermal Patterning, and CDX1/CDX2 Are Required
for LatePS-Induced Mesodermal Patterning
A role for NANOG in mesoderm and endoderm differentiation
has been proposed before by Loh and Lim (2011), but not in
the context of mesoderm subtype specification via PS induction.
We therefore explored the requirement of NANOG for mesoderm
patterning by differentiating hPSCs stably expressing small
hairpin RNAs (shRNA) directed against NANOG (NANOG knock-
down [KD]). NANOG-KD clones could be passaged normally,
and they expressed similar levels of SOX2 and OCT4 as control
cells; they showed moderately activated CDX1/CDX2 but not
TBX6 expression in pluripotency and AnteriorPS conditions (Fig-
ure S6E). Strikingly, depletion of NANOG caused a total absence
of beating structures and reduced the expression of TROPO-T
during cardiac differentiation, but not that of the lateral plate
and extraembryonic mesoderm marker HAND1 (Figure 6E).
NANOG-KD clones could differentiate into somitic mesoderm,
chondrocytes, or SMCs, as seen by expression of PAX3 and
SOX9, Alcian staining analysis, and ACTA2 and CNN1, respec-
tively (Figures 6E and 6F; data not shown). Taken together, these
results show that NANOG is required for the differentiation of An-
teriorPS-derived cardiac mesoderm, but not for LatePS-derived
somitic mesoderm or for ubiquitously derived mesodermal cell
types, such as SMCs.
The requirement forNANOG inanterior (cardiac)mesodermdif-
ferentiation is complementary to the essential role of BRA and
CDX factors in posterior (somitic and extraembryonic) mesoderm
development (van Rooijen et al., 2012). Accordingly, we tested
whether CDX1/CDX2 (which are highly redundant)-KD clones
differentiated into either cardiac or somitic lineages. Although
CDX1/CDX2-KD clones upregulated NKX2.5 during cardiac dif-
ferentiation and formed beating structures similar to the control,
they failed to upregulate PAX3 and SOX9 during somitic differen-
tiation and did not stain for Alcian blue after chondrogenic treat-
ment (Figures 6F and 6G). Furthermore, CDX1/CDX2-KD clones
had a proliferation defect and underwent increased apoptosis in
LatePS and extraembryonic mesoderm differentiation (data not
shown). These results confirmed thatCDX1/CDX2 play a similarly
essential role during LatePS-induced differentiation as NANOG
plays during AnteriorPS-induced differentiation.
Reciprocal Inhibition of NANOG and CDX2 Directs
Patterning into Mesodermal Subtypes
The requirement of NANOG for anterior PS-derived and require-
ment of CDX1/CDX2 for posterior PS-derived mesoderm led usand another 48 hr in F plus B. ACTIVIN signaling in PosteriorPS condition was
ntiation (shown below each panel).
d NKX2-5-GFP HES3 hESCs. Representative confocal images are stained as
K by SP600125 during AnteriorPS condition blocks cardiogenic differentiation
Bisindolylmaleimide II (Bm), and p38 inhibition by SB202190 (Sb202) had no
nel).
ing PS induction.
ESCs induced by PosteriorPS condition (day 1 [D1}/D2) and followed by F plus
lone after 48 hr of DE differentiation with addition of Ch or 4-hydroxy-tamoxifen
nc.
A B C
D E
F G
H I J
Figure 5. LatePS Induction Promotes Subsequent (Pre)SomiticMesodermSpecification in Contrast to PosteriorPS and AnteriorPS Induction
(A) Immunoflow cytometry analysis of FOXA2+ (top gated areas) and EOMES+ (lower right-gated areas) cells induced by AnteriorPS condition with 10, 50, and
100 ng/ml ACTIVIN. Percentages of positive cells are indicated.
(legend continued on next page)
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Mesoderm Induction Patterns Mesodermal Subtypesto askwhether NANOG andCDX2were sufficient to act as deter-
minants of these lineages. We overexpressed NANOG in hPSCs
(NANOG-OE) and placed the resulting clones into AnteriorPS,
PosteriorPS, and LatePS conditions. NANOG-OE clones
differentiated normally in AnteriorPS but not in PosteriorPS and
LatePS conditions (showing increased apoptosis). CDX2 upre-
gulation was blocked depending on ACTIVIN signaling (Figures
7A and S7A; data not shown). Conversely, when we transduced
hPSCs with a lentiviral vector expressing CDX2 to similar
levels as in LatePS, we observed that CDX2 strongly repressed
NANOGbut not SOX2 expression (Figure 7B). CDX2 overexpres-
sion was mutually exclusive of high EOMES and high SOX17
expression at the onset and during AnteriorPS-induced DE dif-
ferentiation (Figures S7B and S7C). Furthermore, BRA was high-
ly induced in CDX2-transduced cells in conditions with ACTIVIN
signaling (Figure S7B). This suggests amutual positive regulation
of CDX2 and BRA, with both acting as key determinants of
posterior mesoderm development (Bernardo et al., 2011; Savory
et al., 2009). Taken together, these results demonstrate a nega-
tive regulatory interaction between NANOG (which acts as an
early specifier of anterior mesoderm and DE) and CDX2 (which
acts as a specifier of posterior mesoderm). Importantly, this
negative interaction loop between NANOG and CDX2 provided
a mechanistic explanation and support for the hypothesis of
mesodermal subtype patterning by PS induction.
Finally, we explored in detail how ACTIVIN and GSK3-b
signalinggradually establish theobserved reciprocal inhibitionbe-
tweenNANOGandCDX2 in pluripotency and at the onset of Ante-
riorPS and LatePS induction. First, we performed a ChIP-qPCR
analysis in AnteriorPS- and LatePS-treated cells using antibodies
against SMAD2/SMAD3, NANOG, b-CATENIN, CDX2, and the
transcriptional repressor TCF7L1 (ortholog of mouse TCF3). We
choseTCF7L1because it is essential formesodermdevelopment,
it is a mediator of GSK3-b signaling that is highly expressed in
hPSCs, and it isaputative targetofNANOGandACTIVINsignaling
(Figure S7E; Brown et al., 2011; Merrill et al., 2004). NANOG,
SMAD2/SMAD3, and in particular TCF7L1 bound putative regula-
tory regions (UCSC/ENCODE; Loh et al., 2014) in intron 1 ofCDX1
andCDX2 in pluripotency and in AnteriorPS-treated cells (Figures
7D, S7D, and 7F). Moreover, TCF7L1 bound to a distal putative
regulatory region of NANOG in LatePS-treated cells after 2 hr
but not after 12 hr of treatment, which is consistent with rapid
NANOG downregulation (Figures 7E and S7E). Unlike TCF7L1,
b-CATENIN remained bound at theCDX1 andCDX2 intron 1 after(B) EGFP-overexpressing H9 hESCs were induced by either AnteriorPS or LatePS
confocal images are shown.
(C) LatePS condition promotes differentiation of cells expressing markers of (
transcript levels in H9 hESCs induced by 2-day PS treatments followed by 2-day
(D) Immunoflow cytometry analysis of SOX9+ and PAX3+ cells induced by indica
LatePS II corresponds to somitic differentiation after 4.5 days.
(E) B treatment during LatePS induction prevents upregulation of PAX3 in presom
(F) Chondrocytes emerge from somitic treatment followed by 10 days of F plus B
(G) Hypothesized human in vitro PS induction and patterning model.
(H) Prolonged differentiation in CDM after somitic differentiation treatment maint
7 days of differentiation are shown.
(I) SMCs resulting from PS induction followed by lateral plate or (pre)somitic treatm
images of SMC markers ACTA2 and CNN2.
(J) Carbachol-induced contraction of SMCs derived from different PS inductions
**p > 0.005 versus D0. Scale bars, 100 mM.
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tative regulatory region of NANOG exclusively in LatePS-treated
cells (Figure 7C). These results are consistent with reports on the
direct regulation of CDX genes by canonical WNT signaling
(Lohnes, 2003). However, much less is known about how this
pathway might regulate NANOG expression and thereby directs
mesoderm patterning by the exit mechanism from pluripotency.
To resolve this question, we sought functional evidence for the
observed transcription factor binding patterns at the NANOG lo-
cus. We used a Luciferase reporter assay to perform a detailed
time course analysis of different NANOG transcriptional regula-
tory regions in AnteriorPS- and LatePS-treated cells. Interest-
ingly, a 2.2 kb fragment upstream of NANOG containing several
putative TCF binding sites inhibited reporter expression after
12 hr but not after 36 hr in LatePS condition (Figure 7G). In
contrast, a short fragment of the NANOG promoter containing
only previously characterized SMAD2/SMAD3 binding sites
was not able to mediate any repression by GSK3-b inhibition
during LatePS treatment. This argues against the possibility
that GSK3-b inhibition impacts on NANOG expression by inter-
fering with SMAD2/SMAD3 signaling. Instead, these results are
consistent with themodel that GSK3-b signaling inhibits NANOG
expression via TCF7L1, which can also interfere with b-CATENIN
binding and function (Wu et al., 2012). In further support of this
hypothesis, transcriptional activation by inducible nuclear D-N-
b-CATENIN could activate CDX2 only in the absence of NANOG
and TCF7L1 when ACTIVIN signaling was inhibited (Figure S7F).
This result finally explained why induced D-N-b-CATENIN alone
did not recapitulate the negative effects of GSK3-b inhibition on
cardiac and endoderm differentiation because these are
most likely mediated by TCF7L1 and its repression of NANOG.
In conclusion, surprisingly early events during mesoderm
induction in hPSCs have dramatic consequences for mesoderm
patterning. The interplay between ACTIVIN/BMP and GSK3-b
signaling during PS induction thereby culminates in the recip-
rocal repression of NANOG and CDX2, enabling direct meso-
derm specification into anterior and posterior subtypes.
DISCUSSION
We have used hPSCs as an experimental model to determine
whether and how PS induction affects subsequent mesoderm
patterning. We found evidence that BRA transcription and PS
mesoderm can be induced independently by either ACTIVIN/condition then mixed and subjected to cardiac differentiation. Representative
pre)somitic (MESP2, TCF15) and somitic (MEOX1, MYF5) mesoderm. Daily
treatment in F plus RA are shown.
ted treatments. LatePS I corresponds to presomitic differentiation after 72 hr.
itic (PSM) differentiation.
. Proteoglycan production was quantified by Alcian blue staining and release.
ains expression of MYF5. Representative confocal images of H9 hESCs after
ents and PDGF plus TGF-b differentiation for 10 days. Representative confocal
.
nc.
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C D
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G
Figure 6. PosteriorPS, AnteriorPS, and LatePS Pattern Mesoderm via NANOG and CDX Factors
(A) GSK3-b inhibition by Ch and ACTIVIN signaling inhibition by Sb repress NANOG and upregulate CDX2. Representative confocal images of H9 hESCs treated
and stained as indicated are shown.
(legend continued on next page)
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brates, mediated by distinct BRA transcriptional regulatory ele-
ments (Harvey et al., 2010). Our results indicate that these
different mechanisms of PS induction produce cells of distinct
identities (PosteriorPS, AnteriorPS, and LatePS) that presage
mesoderm patterning into either lateral plate and cardiac or
(pre)somitic subtypes. However, not all mesodermal cell types
were restricted in their potential by PS induction, as seen with
differentiation of SMCs, which are generated throughout gastru-
lation from all segments of the PS (and from neural crest). It will
be important to determinewhether SMCs derived by these sepa-
rate mesoderm induction methods differ in their susceptibility to
injury or disease (Cheung et al., 2012;Majesky, 2007). In contrast
to SMCs, cardiac and (pre)somitic mesoderm emerge at a
more defined time and place during gastrulation, which might
explain their strong reliance on PS induction conditions. Finally,
by exploring the mechanistic basis of these observations, we
demonstrated that mesoderm patterning is defined by different
exit mechanisms from pluripotency that depend on NANOG
downregulation dynamics and its mutual repression by CDX2.
Based on insights gained here, together with knowledge of
vertebrate gastrulation, we propose a working model and gene
regulatory network of human PS mesoderm induction and
patterning (Figure 7H). At the outset of PS induction, burgeoning
FGF and BMP signals overcome NODAL/ACTIVIN signaling in
the early posterior PS causing rapid downregulation of NANOG
and upregulation of BRA and of CDX2 (major determinant of
extraembryonic mesoderm). In the early anterior PS, increased
NODAL/ACTIVIN signaling, together with FGF and BMP, induces
EOMES and MESP1. Sustained by NOADAL/ACTIVIN signaling,
NANOG, together with SMAD2/SMAD3 and its target TCF7L1,
represses CDX factors that would otherwise block lateral plate,
cardiac, and DE differentiation. In the late PS, FGF and strong
GSK3-b inhibition (with low NODAL/ACTIVIN and BMP signaling)
represses NANOG expression by stimulation of the TCF7L1
repressor. As NANOG and its putative target TCF7L1 become
downregulated, b-CATENIN is able to induce high levels of BRA
and CDX factors, which enables late PS-derived (pre)somitic
mesoderm specification. Finally, we propose that reciprocal inhi-
bition between NANOG and CDX2 similar to that previously
described for the trophoblast and inner cell mass lineages (Chen
et al., 2009) is harnessed during mesoderm development and
patterning.
This model does not depict how moderate differences in
signaling dosagemight lead to even subtler distinctions between
related PS derivatives. Moreover, the precise mechanistic role
of factors like SMAD2/SMAD3 and TCF7L1 in pluripotency
compared to PS induction needs to be addressed. Nevertheless,(B) GSK3-b inhibition strongly represses NANOG expression during the first 24
hESCs treated as indicated is shown.
(C) Inhibition of ACTIVIN signaling by Sb in PosteriorPS condition upregulates CDX
H9 hESCs undergoing LP mesoderm differentiation are shown.
(D) Tamoxifen-inducible activation of DN-b-CATENIN-ER is sufficient to induce BR
and examined by confocal microscopy.
(E) shRNA-mediated KD of NANOG abolishes cardiomyocyte (TROPO-T+) differ
stained as indicated and examined by confocal microscopy.
(F) shRNA-mediated KDs (KD1 and KD2) of CDX1/CDX2 do not affect NKX2-5 an
SOX9 upregulation after somitic treatment and prevent Alcian blue-positive chon
*p < 0.05; **p > 0.005 versus 0 hr, D0, or Control, respectively. Scale bars, 100 m
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murine Wnt3 mutants that can initiate gastrulation and with the
compound Brachyury and Cdx2 knockout phenotypes in mouse
embryos where posterior but not anterior mesoderm and DE are
compromised (van Rooijen et al., 2012; Savory et al., 2009; Tor-
telote et al., 2013). Our findings revise the current concept of the
role of NANOG in pluripotency and mesoderm differentiation to
one that is more consistent with its in vivo expression and func-
tion during early PS- but not late PS-derivedmesodermdevelop-
ment (Osorno et al., 2012).
There are significant conceptual implications of these insights
into human mesoderm and general tissue induction and
patterning. We suggest that what is collectively called PS meso-
derm is instead a collection of specifiedmesodermal tissues with
distinct identities and plasticities. In the mouse embryo, meso-
derm formation begins at embryonic day 6.25 and continues until
the PS disappears almost 3 days later. In humans, this period is
extended further to a week during which the embryo undergoes
dramatic changes in size, morphogenesis, tissue composition,
and signaling. Accordingly, it should not be surprising that
distinct subtypes of mesoderm emerge from hPSC differentia-
tion depending on exposure to different BMP, ACTIVIN, FGF,
and GSK3-b-mediated conditions. However, embryonic meso-
derm might be more plastic and prone to compensation mecha-
nisms, and careful in vivo studies should be used to test the
model presented here.
There are also important practical implications of this study for
hPSC differentiation into mesoderm and its derivatives. Most
significantly, mesodermal cell types that have been difficult to
generate may be produced more efficiently by initiating their dif-
ferentiation through correct PS mesoderm induction and
patterning. Although recent progress in the differentiation of
some mesodermal lineages affirms this assessment (Kennedy
et al., 2012; Mae et al., 2013; Xu et al., 2013), the current study
provides the mechanistic underpinning and comprehensive ex-
planations for it. Not only will this insight have a high impact on
directed differentiation approaches from hPSCs but also it is
likely to affect approaches like transcription factor-mediated re-
programming, which depends on starting cell and (germ layer)
tissue subtype (Ladewig et al., 2013). Moreover, our observa-
tions might extend to neural and nonneural ectoderm induction
and subtype patterning. Like mesodermal development, ecto-
derm patterning is directed by signaling gradients, and in vitro
differentiation into distinct neural subtypes also shows variable
efficiencies. Our insight that different PS mesoderm induction
methods define human mesoderm subtype specification in
hPSCs is therefore likely to have a major impact on the accessi-
bility of key tissues for regenerative medicine.hr of AnteriorPS and Late PS induction. Time course RT-qPCR analysis in H9
2 and inhibits EOMES andMESP1. Treatment protocol and transcript levels in
A but not CDX2 expression. H9 hESCs were induced and stained as indicated
entiation but not somitic (SOX9+, PAX3+) differentiation. Cells were immuno-
d TROPO-T expression during cardiac differentiation but (G) repress PAX3 and
drocyte differentiation.
M.
nc.
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CDX2 NANOG
(legend on next page)
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hPSC Differentiation into PS Mesoderm and Derivatives
hESCs (H9, H7, and HES3-NKX2-5-GFP) and induced PSCs (iPSCs) (BOB)
were grown in chemically defined medium (CDM) with A (10 ng/ml) and F
(12 ng/ml) and as described in the Supplemental Experimental Procedures.
All differentiations were performed in CDM. PosteriorPS condition was
induced by F (20 ng/ml), Ly (10 mM; Sigma-Aldrich), and B (10 ng/ml; R&D Sys-
tems) typically for 36 hr. AnteriorPS condition was induced as PosteriorPS plus
A at either 50 ng/ml for cardiac or 100 ng/ml for DE differentiation. Full DE dif-
ferentiation required 3 days. LatePS condition was induced by F (20 ng/ml) and
Ch (8 mM; Tocris) in CDM without insulin. Lateral plate mesoderm treatment
consisted of F (8 ng/ml) and B (10 ng/ml) for 2 or 4 days in CDM following
PS induction. (Pre)somitic mesoderm was initiated after LatePS induction by
F (4 ng/ml) and RA (1 mM; Sigma-Aldrich) for 36 hr and 4 days for somitic
differentiation. Extraembryonic differentiation was initiated by B (20 ng/ml)
for 3 days following PosteriorPS induction. SMC differentiation was initiated
by TGF-b1 (2 ng/ml) and PDGF-BB (10 ng/ml) following PS induction and
4 days of lateral mesoderm treatment.
Chemically Defined 2D Cardiac Differentiation
One day after passaging, cardiogenic differentiation was initiated after
AnteriorPS induction (with 50 ng/ml of A) by 4 days in F (8 ng/ml), B (10 ng/
ml), IWR1 (1 mM; Tocris), and RA (1 mM; Sigma-Aldrich) followed by 2 days in
CDMwith F plus B. Cells were afterwardsmaintained in CDM.Onset of beating
was observed on day 7 or 8 of differentiation in clusters (low initial colony den-
sity) or sheets (high initial colony density). The method was also routinely per-
formed on hESC lines H7 and HES3 as well as in several human iPSC lines.
Chondrogenic Differentiation and Alcian Blue Staining
Chondrocyte differentiation was initiated after LatePS induction and 4 days of
somitic treatment (F plus RA) by F (8 ng/ml) and B (10 ng/ml) in CDM for
10 days. For Alcian blue staining, cells were fixed in 4% paraformaldehyde,
washed with PBS, and stained in 0.025% Alcian solution (pH 2.0).
Flow Cytometry
For quantitative analysis of BRA-Venus-H2B reporter gene activity and intra-
cellular transcription factor staining, cells were grown in different conditions
and then dissociated into single cells using Cell Dissociation Buffer (Gibco).
Cells were washed with PBS, where appropriate, stained as described
previously (BD Biosciences; Bernardo et al., 2011), and run on a CyAn ADP
flow cytometer (Beckman Coulter).
ChIP
ChIP was carried out as described previously by Brown et al. (2011) with the
modification that pluripotent and differentiated hESCs were fixed in Hank’s
balanced salt solution (pH 7.6) containing 1% formaldehyde and protein
crosslinkers disodium phosphate and tryptose phosphate broth (Sigma-
Aldrich) for 20 min at room temperature. Antibodies and primers are
described in the Supplemental Experimental Procedures. Results were
expressed as relative pull-down amount when normalized against the immu-
noglobulin G control ChIP for the same region, and fold change was calcu-
lated. Relative enrichments were then compared to a control region. Data
are representative of three experiments performed on the same day, and
error bars indicate SD.Figure 7. Reciprocal Inhibition of NANOG and CDX2 Directs Early Spe
(A) NANOG repression of CDX2 depends on ACTIVIN signaling.
(B) Lentiviral CDX2 overexpression inhibits NANOG but not SOX2 expression in pl
H9 hESCs are shown.
(C) CDX2 and NANOG ChIP-qPCR at the NANOG locus.
(D) NANOG and SMAD2/SMAD3 ChIP-qPCR at the CDX2 locus.
(E) TCF7L1 and b-CATENIN ChIP-qPCR binding analysis at the NANOG and (F)
(G) Luciferase reporter analysis of transiently transfected H9 hESCs with indicate
(H) Human in vitro PS induction model outlining the gene regulatory network tha
*p < 0.05; **p > 0.005 versus control or pairwise as indicated with bar. Scale bar
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Statistical significance of quantitative data was determined by applying a two-
tailed Student’s test to raw values or to the average values obtained from
independent experiments. Detailed Experimental Procedures and informa-
tion about used reagents can be found in the Supplemental Experimental
Procedures.
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